• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰变加速因子mRNA和补体C3 mRNA在人类病变肾脏中的表达

Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney.

作者信息

Abe K, Miyazaki M, Koji T, Furusu A, Ozono Y, Harada T, Sakai H, Nakane P K, Kohno S

机构信息

Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

出版信息

Kidney Int. 1998 Jul;54(1):120-30. doi: 10.1046/j.1523-1755.1998.00961.x.

DOI:10.1046/j.1523-1755.1998.00961.x
PMID:9648070
Abstract

BACKGROUND

Decay accelerating factor (DAF), a product of mesangial cells in vitro, is expressed on the surface of cells and is a candidate for the focal suppression of complement activation. It is not clear at present whether the levels of expression of DAF and intrarenal C3 synthesis correlate with the level of tissue injury.

METHODS

Immunohistochemistry for DAF and C3 and nonradioactive in situ hybridization with digoxigenin-labeled oligonucleotide probe for DAF and C3 mRNA were performed in 22 tissue samples of kidneys from patients with IgA nephropathy (IgAN), 6 with membranous nephropathy (MN), 6 with lupus nephritis (LN), and five normal kidneys.

RESULTS

In the normal kidney, DAF was confined to the juxtaglomerular apparatus and little or no C3 was detected; however, a few glomerular cells were positive for DAF mRNA but no C3 mRNA positive cells were detected. In diseased kidneys, DAF and C3 as well as their mRNAs were detected in mesangial cells, tubular cells and infiltrating cells. Glomerular epithelial cells and Bowman's capsule cells contained little or no DAF and C3 but were positive for their mRNAs. The mean percentages of mesangial cells positive for DAF and C3 mRNAs were 49.3 +/- 11.5% and 50.7 +/- 10.3% in IgAN, and 17.0 +/- 6.3% and 19.4 +/- 9.0% in MN, respectively. The percentage of mesangial cells positive for DAF and C3 mRNAs among intraglomerular cells correlated positively with the degree of mesangial proliferation and glomerular sclerosis in IgAN. In contrast, in LN the percentage of glomerular cells positive for DAF mRNA correlated negatively with the degree of glomerular injury, while the percentage of cells positive for C3 mRNA did not change with the progression of the disease. The ratio of C3 mRNA/DAF mRNA of glomerular cells correlated with the degree of glomerular injury in both IgAN and LN. In the tubulointerstitium, the percentage of cells expressing mRNA, and C3 mRNA/DAF mRNA radio correlated with the degree of tubular atrophy and interstitial broadening in both IgAN and LN.

CONCLUSIONS

We conclude that DAF and C3 mRNAs are synthesized in human diseased kidneys, and that a balance between locally synthesized DAF and C3 may be important in the progression of glomerulonephritis.

摘要

背景

衰变加速因子(DAF)是体外系膜细胞的产物,表达于细胞表面,是补体激活局部抑制的候选因子。目前尚不清楚DAF的表达水平和肾内C3合成是否与组织损伤程度相关。

方法

对22例IgA肾病(IgAN)患者、6例膜性肾病(MN)患者、6例狼疮性肾炎(LN)患者的肾组织样本以及5例正常肾脏进行DAF和C3的免疫组化检测,并用地高辛标记的寡核苷酸探针进行DAF和C3 mRNA的非放射性原位杂交。

结果

在正常肾脏中,DAF局限于肾小球旁器,几乎未检测到C3;然而,少数肾小球细胞DAF mRNA呈阳性,但未检测到C3 mRNA阳性细胞。在患病肾脏中,系膜细胞、肾小管细胞和浸润细胞中可检测到DAF和C3及其mRNA。肾小球上皮细胞和鲍曼囊细胞几乎不含有DAF和C3,但它们的mRNA呈阳性。IgAN中系膜细胞DAF和C3 mRNA阳性的平均百分比分别为49.3±11.5%和50.7±10.3%,MN中分别为17.0±6.3%和19.4±9.0%。IgAN中肾小球内DAF和C3 mRNA阳性的系膜细胞百分比与系膜增生和肾小球硬化程度呈正相关。相反,在LN中,DAF mRNA阳性的肾小球细胞百分比与肾小球损伤程度呈负相关,而C3 mRNA阳性细胞百分比不随疾病进展而变化。肾小球细胞C3 mRNA/DAF mRNA比值在IgAN和LN中均与肾小球损伤程度相关。在肾小管间质中,IgAN和LN中表达mRNA的细胞百分比以及C3 mRNA/DAF mRNA比值与肾小管萎缩和间质增宽程度相关。

结论

我们得出结论,DAF和C3 mRNA在人类患病肾脏中合成,局部合成的DAF和C3之间的平衡可能在肾小球肾炎进展中起重要作用。

相似文献

1
Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney.衰变加速因子mRNA和补体C3 mRNA在人类病变肾脏中的表达
Kidney Int. 1998 Jul;54(1):120-30. doi: 10.1046/j.1523-1755.1998.00961.x.
2
Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy.IgA肾病中补体C3在肾小球内的合成及其激活产物
Nephron. 2001 Mar;87(3):231-9. doi: 10.1159/000045920.
3
Intraglomerular C3 synthesis in human kidney detected by in situ hybridization.通过原位杂交检测人肾内肾小球C3合成。
J Am Soc Nephrol. 1996 Nov;7(11):2428-33. doi: 10.1681/ASN.V7112428.
4
Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization.通过原位杂交评估人类患病肾脏中补体C5a受体mRNA的表达增强。
Kidney Int. 2001 Jul;60(1):137-46. doi: 10.1046/j.1523-1755.2001.00780.x.
5
Involvement of IL-4 in human glomerulonephritis: an in situ hybridization study of IL-4 mRNA and IL-4 receptor mRNA.白细胞介素-4在人类肾小球肾炎中的作用:白细胞介素-4信使核糖核酸和白细胞介素-4受体信使核糖核酸的原位杂交研究
J Am Soc Nephrol. 1997 May;8(5):730-41. doi: 10.1681/ASN.V85730.
6
Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.肾素-血管紧张素系统成分在IgA肾病中的组织特异性表达。
Am J Nephrol. 2005 Jan-Feb;25(1):1-12. doi: 10.1159/000083224. Epub 2005 Jan 7.
7
Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.基质金属蛋白酶 2 和 9 及其组织抑制剂 2 和 1 在人类肾小球疾病肾小球中的表达:免疫荧光、原位杂交和免疫电镜研究结果。
Clin Exp Nephrol. 2012 Dec;16(6):863-74. doi: 10.1007/s10157-012-0633-3. Epub 2012 May 22.
8
[PPAR-gamma expression in the kidney of actively proliferating glomerulonephritis].[增殖性肾小球肾炎患者肾脏中过氧化物酶体增殖物激活受体γ的表达]
Beijing Da Xue Xue Bao Yi Xue Ban. 2003 Oct;35(5):499-502.
9
Intraglomerular C3 synthesis in rats with passive Heymann nephritis.被动型海曼肾炎大鼠的肾小球内C3合成
Am J Pathol. 1997 Nov;151(5):1249-56.
10
C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.IgA肾病患者肾活检标本中C3、C4、B因子和HLA-DRα mRNA表达
Immunology. 1995 Dec;86(4):575-83.

引用本文的文献

1
Proteomics and Incident Kidney Failure in Individuals With CKD: The African American Study of Kidney Disease and Hypertension and the Boston Kidney Biopsy Cohort.慢性肾脏病患者的蛋白质组学与新发肾衰竭:非裔美国人肾脏疾病与高血压研究及波士顿肾脏活检队列研究
Kidney Med. 2024 Oct 16;6(12):100921. doi: 10.1016/j.xkme.2024.100921. eCollection 2024 Dec.
2
Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury.血红素加氧酶-1(HO-1)对肾脏损伤中补体激活的调节作用
Antioxidants (Basel). 2021 Jan 6;10(1):60. doi: 10.3390/antiox10010060.
3
Comparative proteomic analysis identifies biomarkers for renal aging.
比较蛋白质组学分析鉴定出与肾脏衰老相关的生物标志物。
Aging (Albany NY). 2020 Nov 6;12(21):21890-21903. doi: 10.18632/aging.104007.
4
Current Understanding of the Role of Complement in IgA Nephropathy.对补体在IgA肾病中作用的当前认识。
J Am Soc Nephrol. 2015 Jul;26(7):1503-12. doi: 10.1681/ASN.2014101000. Epub 2015 Feb 18.
5
Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.表达Afa/Dr黏附素的人类弥漫性黏附大肠杆菌(Afa/Dr DAEC)的发病机制:当前见解与未来挑战
Clin Microbiol Rev. 2014 Oct;27(4):823-69. doi: 10.1128/CMR.00036-14.
6
Complement and HIV-I infection/HIV-associated neurocognitive disorders.补体与 HIV-1 感染/与 HIV 相关的神经认知障碍。
J Neurovirol. 2014 Apr;20(2):184-98. doi: 10.1007/s13365-014-0243-9. Epub 2014 Mar 18.
7
Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine.人尿中肾小球膜囊泡的亚分级、表征及深入蛋白质组学分析
Kidney Int. 2014 May;85(5):1225-37. doi: 10.1038/ki.2013.422. Epub 2013 Nov 6.
8
Review: Complement and its regulatory proteins in kidney diseases.综述:肾脏疾病中的补体及其调节蛋白。
Nephrology (Carlton). 2010 Oct;15(7):663-75. doi: 10.1111/j.1440-1797.2010.01373.x.
9
Involvement of bone marrow-derived endothelial progenitor cells in glomerular capillary repair in habu snake venom-induced glomerulonephritis.骨髓来源的内皮祖细胞参与竹叶青蛇毒诱导的肾小球肾炎中肾小球毛细血管的修复
Virchows Arch. 2008 Jul;453(1):97-106. doi: 10.1007/s00428-008-0618-5. Epub 2008 Jun 13.
10
Immunopathogenesis of IgAN.IgA肾病的免疫发病机制。
Semin Immunopathol. 2007 Nov;29(4):427-43. doi: 10.1007/s00281-007-0089-9. Epub 2007 Sep 13.